161 related articles for article (PubMed ID: 993583)
1. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
Chism SE; Wallis S; Burton RC; Warner NL
J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
Burton RC; Chism SE; Warner NL
J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
4. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
5. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
8. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice.
Barsoum AL; Coggin JH
J Biol Response Mod; 1989 Dec; 8(6):579-92. PubMed ID: 2600602
[TBL] [Abstract][Full Text] [Related]
11. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
[TBL] [Abstract][Full Text] [Related]
12. Fetal antigens associated with adenovirus 12 mouse tumors.
Akagi T
Acta Med Okayama; 1976 Dec; 30(6):385-95. PubMed ID: 138333
[TBL] [Abstract][Full Text] [Related]
13. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
Giorgi JV; Warner NL
J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
[TBL] [Abstract][Full Text] [Related]
14. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
Callahan GN
J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
[TBL] [Abstract][Full Text] [Related]
15. T-cell-mediated antitumor immune response induced by oncofetal antigens.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
[TBL] [Abstract][Full Text] [Related]
16. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
Ogata M; Shimizu J; Kosaka H; Maekawa R; Shimizu K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
[TBL] [Abstract][Full Text] [Related]
17. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
Burton RC; Warner NL
Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
Kaneko Y; Natsuume-Sakai S; Migita S
J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
[No Abstract] [Full Text] [Related]
19. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
20. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene.
Ménard S; Colnaghi MI; Della Porta G
Cancer Res; 1973 Mar; 33(3):478-81. PubMed ID: 4689897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
